Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Sonnet BioTherapeutics Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

		Security Type		Security Class Title		Fee Calculation or Carry Forward Rule		Amount Registered (1)				Proposed Maximum Offering Price Per Share				Maximum Aggregate Offering Price				Fee Rate				Amount of Registration Fee
Fees to Be Paid		Equity		Common Stock, $0.0001 par value per share		457 (c)			2,000,000	(2)		$	1.52	(3)		$	3,040,000				0.00015310			$	465.42
		Total Fees Previously Paid																						$	—
		Total Fee Offsets																						$	—
		Net Fee Due																						$	465.42

(1)	Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate number of additional shares of common stock, par value $0.0001 per share (“Common Stock”), of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) as may be issued or issuable because of stock splits, stock dividends, stock distributions, and similar transactions.

(2)	Includes 2,000,000 shares of Common Stock that are available to be issued and sold by the Company to Chardan Capital Markets LLC (“Chardan”) from time to time at the Company’s election pursuant to a ChEF Purchase Agreement, dated as of May 2, 2024 and amended January 10, 2025, between the Company and Chardan, subject to satisfaction of the conditions set forth therein.

(3)	Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the shares of Common Stock on The Nasdaq Stock Market on January 15, 2025. This calculation is in accordance with Rule 457(c) of the Securities Act.